Search research articles
Contact Us
Filters
Showing results (51-60 of 89) with videos related to
Page
of 9
Sort By:
Neurology
|
June 20, 1998
Quantitative analysis of cerebral vasculopathy in patients with Fabry disease
K E Crutchfield, N J Patronas, J M Dambrosia, et al.
American Journal of Human Genetics
|
August 12, 1999
Mapping of the mucolipidosis type IV gene to chromosome 19p and definition of founder haplotypes
S A Slaugenhaupt, J S Acierno, L A Helbling, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
July 17, 1998
Proton magnetic resonance spectroscopic imaging in the clinical evaluation of patients with Niemann-Pick type C disease
G Tedeschi, S Bonavita, N W Barton, et al.
Clinical Genetics
|
September 5, 2001
Identification of fifteen novel mutations and genotype-phenotype relationship in Fabry disease
G M Altarescu, L G Goldfarb, K Y Park, et al.
Journal of Inherited Metabolic Disease
|
August 6, 2009
Management of neuronopathic Gaucher disease: revised recommendations
A Vellodi, A Tylki-Szymanska, E H Davies, et al.
Neurology
|
March 29, 2001
Evidence for neuroaxonal injury in patients with proteolipid protein gene mutations
S Bonavita, R Schiffmann, D F Moore, et al.
JAMA
|
June 21, 2001
Enzyme replacement therapy in Fabry disease: a randomized controlled trial
R Schiffmann, J B Kopp, H A Austin, et al.
Molecular Genetics and Metabolism
|
June 18, 2003
Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism?
N Tayebi, J Walker, B Stubblefield, et al.
The Journal of Pediatrics
|
April 11, 2001
The efficacy of enzyme replacement therapy in patients with chronic neuronopathic Gaucher's disease
G Altarescu, S Hill, E Wiggs, et al.
Neurology
|
April 24, 1999
Quantitative analysis of epidermal innervation in Fabry disease
L J Scott, J W Griffin, C Luciano, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 89) with videos related to
Sort By:
Page
of 9
Neurology
|
June 20, 1998
Quantitative analysis of cerebral vasculopathy in patients with Fabry disease
K E Crutchfield, N J Patronas, J M Dambrosia, et al.
American Journal of Human Genetics
|
August 12, 1999
Mapping of the mucolipidosis type IV gene to chromosome 19p and definition of founder haplotypes
S A Slaugenhaupt, J S Acierno, L A Helbling, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
July 17, 1998
Proton magnetic resonance spectroscopic imaging in the clinical evaluation of patients with Niemann-Pick type C disease
G Tedeschi, S Bonavita, N W Barton, et al.
Clinical Genetics
|
September 5, 2001
Identification of fifteen novel mutations and genotype-phenotype relationship in Fabry disease
G M Altarescu, L G Goldfarb, K Y Park, et al.
Journal of Inherited Metabolic Disease
|
August 6, 2009
Management of neuronopathic Gaucher disease: revised recommendations
A Vellodi, A Tylki-Szymanska, E H Davies, et al.
Neurology
|
March 29, 2001
Evidence for neuroaxonal injury in patients with proteolipid protein gene mutations
S Bonavita, R Schiffmann, D F Moore, et al.
JAMA
|
June 21, 2001
Enzyme replacement therapy in Fabry disease: a randomized controlled trial
R Schiffmann, J B Kopp, H A Austin, et al.
Molecular Genetics and Metabolism
|
June 18, 2003
Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism?
N Tayebi, J Walker, B Stubblefield, et al.
The Journal of Pediatrics
|
April 11, 2001
The efficacy of enzyme replacement therapy in patients with chronic neuronopathic Gaucher's disease
G Altarescu, S Hill, E Wiggs, et al.
Neurology
|
April 24, 1999
Quantitative analysis of epidermal innervation in Fabry disease
L J Scott, J W Griffin, C Luciano, et al.
Page
of 9